Similar articles

• A humanized mouse model for a common beta0-thalassemia mutation.

  Jamsai D, Zaibak F, Khongnium W, Vadolas J, Voullaire L, Fowler KJ, Gazeas S, Fucharoen S, Williamson R, Ioannou PA. Jamsai D, et al. Genomics. 2005 Apr;85(4):453-61. doi: 10.1016/j.ygeno.2004.11.016. Genomics. 2005. PMID: 15780748
• Expression of the globin genes and hematopoiesis in beta-thalassemic mice.

  Popp RA, Bolch SL, Shinpock SG, Popp DM. Popp RA, et al. Adv Exp Med Biol. 1989;271:161-76. doi: 10.1007/978-1-4613-0623-8_17. Adv Exp Med Biol. 1989. PMID: 2486282 No abstract available.
• A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.

  Li W, Xie S, Guo X, Gong X, Wang S, Lin D, Zhang J, Ren Z, Huang S, Zeng F, Zeng Y. Li W, et al. Haematologica. 2008 Mar;93(3):356-62. doi: 10.3324/haematol.12010. Epub 2008 Feb 11. Haematologica. 2008. PMID: 18268280
• Issues to consider when phenotyping mutant mouse models.

  Murray KA. Murray KA. Lab Anim (NY). 2002 Feb;31(2):25-9. doi: 10.1038/5000123. Lab Anim (NY). 2002. PMID: 11910405 Review. No abstract available.
• Mutant mouse pathology: an exercise in integration.

  Zeiss CJ. Zeiss CJ. Lab Anim (NY). 2002 Feb;31(2):34-9. doi: 10.1038/5000124. Lab Anim (NY). 2002. PMID: 11910406 Review. No abstract available.